Articles

Over the past three decades, there has been a gradual yet steady increase in survivorship awareness, resources, and services. Although none of this has happened easily or rapidly, there is no doubt that the concept of cancer survivorship is here to stay. Read More ›

Women with Dense Breasts at Increased Risk for Subsequent Breast Cancer after DCIS

TON - Daily

Women with ductal carcinoma in situ (DCIS) who have mammographically dense breasts may be at increased risk for subsequent breast cancer, especially in the contralateral breast, researchers at Kaiser Permanente report.

TON - Daily

A study of men with a family history of breast cancer revealed that nearly 80% were unaware of their own risk for breast cancer, and all of them said that their healthcare provider had not discussed the disease with them.

TON - Daily

Although commonly referred to as “chemobrain” and described most often in women with breast cancer, cognitive impairments may occur in patients with other types of cancer and after hormonal and radiation therapies as well, a new study suggests. Another recent study was the first to use imaging to show changes in brain tissue in women undergoing chemotherapy.

TON - Daily

Preliminary results of an ongoing trial suggest that a combination of trastuzumab, bevacizumab, and docetaxel is safe and effective as first-line therapy in women with metastatic breast cancer (MBC).

Fourteen of the 18 patients treated to date had a partial response or stable disease, a clinical benefit rate of 77.7, the investigators report.

TON - Daily

Adding the monoclonal antibody rituximab to chemotherapy signicantly increases both progression-free and overall survival in previously untreated patients with chronic lymphocytic leukemia (CLL), the German Lymphocytic Leukemia Study Group reports.

TON - Daily

The recently approved taxane cabazitaxel significantly improved overall survival in men with castration-resistant prostate cancer in a multinational phase 3 study.

The TROPIC investigators found that men treated with cabazitaxel plus prednisone had 30% lower risk of death compared with patients treated with mitoxantrone plus prednisone.

TON - Daily

Results of a trial by the Children's Oncology Group indicate that children with intermediate-risk neuroblastoma can be successfully treated with a shorter duration and lower doses of chemotherapy than are currently used.

Findings from the phase 3 trial reported in the September 30, 2010, issue of the New England Journal of Medicine may change the approach to treating the disease, which affects 650 children in the United States each year.

TON - Daily

Surgery provides excellent long-term cancer control and high survival rates for men with aggressive prostate cancer, a new study suggests.

In the study by researchers from the Mayo Clinic, Rochester, Minnesota, and Fox Chase Cancer Center, Philadelphia, men with high-risk prostate cancer who underwent radical prostatectomy had a 10-year cancer-specific survival rate of 92% and an overall survival rate of 77%.

TON - Daily

Findings of a new study demonstrate the benefit of early referral of young women with breast cancer to reproductive specialists for fertility preservation.

The study, reported online September 27 in the Journal of Clinical Oncology, showed that referral to reproductive specialists before breast surgery increases the likelihood of obtaining a sufficient number of oocytes for fertility preservation without delaying breast cancer treatment.

Articles

View the Latest Issue of TON

Subscribe Today!

I'd like to receive:

Articles

Page 364 of 376

View the Latest Issue of TON

Subscribe Today!

I'd like to receive: